<DOC>
	<DOCNO>NCT02172404</DOCNO>
	<brief_summary>Trial compare administration technique HandiHaler® vs. MDI , compare learn retention administration technique HandiHaler® vs. MDI compare ease use HandiHaler® vs. MDI</brief_summary>
	<brief_title>HandiHaler® vs. Metered Dose Inhaler ( MDI ) Patients With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<criteria>Diagnosis chronic obstructive pulmonary disease must meet follow spirometric criterion : Historical data ( old 6 month ) stable airway obstruction force expiratory volume one second ( FEV1 ) ≤ 80 % predict normal FEV1 ≤ 70 % forced vital capacity ( FVC ) Male female patient 40 year age old Smokers exsmokers smoke history 10 packyears Currently use prescription bronchodilator ( Atrovent® , Berodual® , Combivent® , salbutamol , etc . ) administer least daily Able read understand write instruction , understand verbal instruction fill write questionnaire regard device Able give inform consent prior participation trial , include discontinuation medication , sign approve consent form , willing able complete trial procedure Any acute chronic illness could interfere conduct completion trial , include limited cardiovascular , renal , neurologic , liver , immunologic , endocrine dysfunction clinically significant Current recent ( past 2 year ) history drug alcohol abuse Participation clinical trial use investigational drug within last 30 day prior visit 1 Experience HandiHaler® Discontinued use regularly prescribe use MDI within last 12 month . Treatment oral injectable βblockers within recent 4 week prior visit 1 Treatment oral βadrenergics within recent 4 week prior visit 1 Current recent ( last 6 week prior visit 1 ) respiratory illness include , limited upper low respiratory tract infection asthma Patients pulmonary rehabilitation program complete pulmonary rehabilitation program 6 week prior visit 1 Patients know hypersensitivity ipratropium bromide , lactose component inhalation capsule delivery system Patients known sensitivity inhaled βagonists Patient use oral corticosteroid medication unstable dos ( i.e. , less 6 week stable dose ) dose excess equivalent 10 mg prednisolone per day 20 mg every day Pregnant nursing woman woman childbearing potential use medically approve mean contraception</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>